{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:56:52Z","timestamp":1792447012360,"version":"4.5.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s40261-017-0498-z","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T11:29:13Z","timestamp":1487071753000},"page":"423-437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Neuropsychiatric Effects of Antimicrobial Agents"],"prefix":"10.1007","volume":"37","author":[{"given":"Nicholas","family":"Zareifopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Panayiotakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"issue":"3","key":"498_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","volume":"72","author":"MF Grill","year":"2011","unstructured":"Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011;72(3):381\u201393.","journal-title":"Br J Clin Pharmacol."},{"issue":"8","key":"498_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2165\/11534340-000000000-00000","volume":"24","author":"JS Kass","year":"2010","unstructured":"Kass JS, Shandera WX. Nervous system effects of antituberculosis therapy. CNS Drugs. 2010;24(8):655\u201367.","journal-title":"CNS Drugs."},{"issue":"1","key":"498_CR3","first-page":"66","volume":"15","author":"NE Neff","year":"2002","unstructured":"Neff NE, Kuo G. Acute manic psychosis induced by triple therapy for H. pylori. J Am Board Fam Pract. 2002;15(1):66\u20138.","journal-title":"J Am Board Fam Pract."},{"issue":"1\u20133","key":"498_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.schres.2009.05.005","volume":"112","author":"FB Dickerson","year":"2009","unstructured":"Dickerson FB, Stallings CR, Boronow JJ, Origoni AE, Yolken RH. A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii. Schizophr Res. 2009;112(1\u20133):198\u2013219.","journal-title":"Schizophr Res."},{"issue":"6","key":"498_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ckj\/sfu098","volume":"7","author":"TK-W Ma","year":"2014","unstructured":"Ma TK-W, Chow K-M, Choy ASM, Kwan BC-H, Szeto C-C, Li PK-T. Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients. Clin Kidney J. 2014;7(6):507\u201312.","journal-title":"Clin Kidney J."},{"issue":"7","key":"498_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.biopsych.2004.12.035","volume":"57","author":"LA Snider","year":"2005","unstructured":"Snider LA, Lougee L, Slattery M, Grant P, Swedo SE. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry. 2005;57(7):788\u201392.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"498_CR7","doi-asserted-by":"publisher","first-page":"e002857","DOI":"10.1136\/bmjopen-2013-002857","volume":"3","author":"JL Fleet","year":"2013","unstructured":"Fleet JL, Shariff SZ, Bailey DG, et al. Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions. BMJ Open. 2013;3(7):e002857.","journal-title":"BMJ Open."},{"issue":"6","key":"498_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0090-3019(03)00065-X","volume":"59","author":"LA Cone","year":"2003","unstructured":"Cone LA, Padilla L, Potts BE. Delirium in the elderly resulting from azithromycin therapy. Surg Neurol. 2003;59(6):509\u201311.","journal-title":"Surg Neurol"},{"issue":"12","key":"498_CR9","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1128\/AAC.00840-10","volume":"54","author":"D Bertrand","year":"2010","unstructured":"Bertrand D, Bertrand S, Neveu E, Fernandes P. Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors. Antimicrob Agents Chemother. 2010;54(12):5399\u2013402.","journal-title":"Antimicrob Agents Chemother."},{"issue":"6","key":"498_CR10","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/bjp.2008.313","volume":"155","author":"Y Hatanaka","year":"2008","unstructured":"Hatanaka Y, Zamami Y, Koyama T, et al. A ketolide antibiotic, telithromycin, inhibits vascular adrenergic neurotransmission in the rat mesenteric vascular bed. Br J Pharmacol. 2008;155(6):826\u201336.","journal-title":"Br J Pharmacol."},{"issue":"5","key":"498_CR11","first-page":"827","volume":"24","author":"R Lopes","year":"2011","unstructured":"Lopes R, Rodrigues R, Domingues I, Curral R, Roma-Torres A. Antibiomania: a case of a manic episode induced by clarithromycin. Acta Med Port. 2011;24(5):827\u201332.","journal-title":"Acta Med Port."},{"issue":"5","key":"498_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4103\/0253-7613.140593","volume":"46","author":"A Mishra","year":"2014","unstructured":"Mishra A, Pandya HV, Dave N, Mathew M, Sapre CM, Chaudhary S. A rare debilitating neurological adverse effect of ranolazine due to drug interaction with clarithromycin. Indian J Pharmacol. 2014;46(5):547\u20138.","journal-title":"Indian J Pharmacol."},{"issue":"2","key":"498_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/NMD.0000000000000251","volume":"203","author":"EB Dinca","year":"2015","unstructured":"Dinca EB, Skinner A, Dinca RV, Tudose C. The dangers of gastritis: a case of clarithromycin-associated brief psychotic episode. J Nerv Ment Dis. 2015;203(2):149\u201351.","journal-title":"J Nerv Ment Dis."},{"issue":"1","key":"498_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/S1461145703003882","volume":"7","author":"A Ort\u0131z-Dom\u0131nguez","year":"2004","unstructured":"Ort\u0131z-Dom\u0131nguez A, Berlanga C, Gutierrez-Mora D. A case of clarithromycin-induced manic episode (antibiomania). Int J Neuropsychopharmacol. 2004;7(1):99\u2013100.","journal-title":"Int J Neuropsychopharmacol."},{"issue":"3","key":"498_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1600-0447.2009.01522.x","volume":"122","author":"WJ Baranowski","year":"2010","unstructured":"Baranowski WJ. Clarithromycin-induced hypomania in a child\u2014a case report. Acta Psychiatr Scand. 2010;122(3):267\u20138.","journal-title":"Acta Psychiatr Scand."},{"issue":"5","key":"498_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5414\/CPP49297","volume":"49","author":"WJ Baranowski","year":"2011","unstructured":"Baranowski WJ. Clarithromycin-induced hypersomnia in children. Int J Clin Pharmacol Ther. 2011;49(5):297\u20139.","journal-title":"Int J Clin Pharmacol Ther."},{"issue":"3","key":"498_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jocn.2010.08.014","volume":"18","author":"M Bandettini di Poggio","year":"2011","unstructured":"Bandettini di Poggio M, Anfosso S, Audenino D, Primavera A. Clarithromycin-induced neurotoxicity in adults. J Clin Neurosci. 2011;18(3):313\u20138.","journal-title":"J Clin Neurosci."},{"issue":"11","key":"498_CR18","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1176\/appi.ajp.162.11.2033","volume":"162","author":"JO Brooks 3rd","year":"2005","unstructured":"Brooks JO 3rd, Hoblyn JC. Secondary mania in older adults. Am J Psychiatry. 2005;162(11):2033\u20138.","journal-title":"Am J Psychiatry."},{"key":"498_CR19","doi-asserted-by":"publisher","unstructured":"Liu EY, Vasudev A. Mania induced by clarithromycin in a geriatric patient taking low-dose prednisone. Prim Care Companion CNS Disord. 2014;16(3). doi: 10.4088\/PCC.14l01626 .","DOI":"10.4088\/PCC.14l01626"},{"issue":"11","key":"498_CR20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5664\/jcsm.3176","volume":"9","author":"E Rezvanian","year":"2013","unstructured":"Rezvanian E, Watson NF. Kleine\u2013Levin syndrome treated with clarithromycin. J Clin Sleep Med. 2013;9(11):1211\u20132.","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"498_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5664\/jcsm.3634","volume":"10","author":"LM Trotti","year":"2014","unstructured":"Trotti LM, Bliwise DL, Rye DB. Further experience using clarithromycin in patients with Kleine\u2013Levin syndrome. J Clin Sleep Med. 2014;10(4):457\u20138.","journal-title":"J Clin Sleep Med."},{"issue":"1","key":"498_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1378\/chest.14-1304","volume":"148","author":"Z Khan","year":"2015","unstructured":"Khan Z, Trotti LM. Central disorders of hypersomnolence: focus on the narcolepsies and idiopathic hypersomnia. Chest. 2015;148(1):262\u201373.","journal-title":"Chest."},{"issue":"3","key":"498_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.24459","volume":"78","author":"LM Trotti","year":"2015","unstructured":"Trotti LM, Saini P, Bliwise DL, Freeman AA, Jenkins A, Rye DB. Clarithromycin in \u03b7-aminobutyric acid-related hypersomnolence: a randomized, crossover trial. Ann Neurol. 2015;78(3):454\u201365.","journal-title":"Ann Neurol."},{"issue":"7","key":"498_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/0269881113515062","volume":"28","author":"LM Trotti","year":"2014","unstructured":"Trotti LM, Saini P, Freeman AA, Bliwise DL, Garcia PS, Jenkins A, Rye DB. Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: clinical experience. J Psychopharmacol. 2014;28(7):697\u2013702.","journal-title":"J Psychopharmacol."},{"issue":"7","key":"498_CR25","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1111\/j.1476-5381.1995.tb15957.x","volume":"116","author":"M Fujimoto","year":"1995","unstructured":"Fujimoto M, Munakata M, Akaike N. Dual mechanisms of GABAA response inhibition by beta-lactam antibiotics in the pyramidal neurones of the rat cerebral cortex. Br J Pharmacol. 1995;116(7):3014\u201320.","journal-title":"Br J Pharmacol."},{"issue":"2","key":"498_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/sj.bjp.0704496","volume":"135","author":"M Sugimoto","year":"2002","unstructured":"Sugimoto M, Fukami S, Kayakiri H, et al. The \u03b2-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABAA receptors. Br J Pharmacol. 2002;135(2):427\u201332.","journal-title":"Br J Pharmacol."},{"issue":"2","key":"498_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/sj.bjp.0703063","volume":"129","author":"JC Behrends","year":"2000","unstructured":"Behrends JC. Modulation by bicuculline and penicillin of the block by t-butyl-bicyclo-phosphorothionate (TBPS) of GABAA-receptor mediated Cl\u2212-current responses in rat striatal neurones. Br J Pharmacol. 2000;129(2):402\u20138.","journal-title":"Br J Pharmacol."},{"key":"498_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mcn.2014.10.001","volume":"63","author":"AV Rossokhin","year":"2014","unstructured":"Rossokhin AV, Sharonova IN, Bukanova JV, Kolbaev SN, Skrebitsky VG. Block of GABAA receptor ion channel by penicillin: electrophysiological and modeling insights toward the mechanism. Mol Cell Neurosci. 2014;63:72\u201382.","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"498_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1460-9592.2006.01861.x","volume":"16","author":"I Hoigne-Li\u0161pfe","year":"2006","unstructured":"Hoigne-Li\u0161pfe I, Ja\u0161hr M. Psychiatric symptoms after anesthesia: antibiomania or Hoigne\u2019s syndrome? Paediatr Anaesth. 2006;16(4):498\u20139.","journal-title":"Paediatr Anaesth."},{"issue":"3","key":"498_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","volume":"45","author":"M Sugimoto","year":"2003","unstructured":"Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N. Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003;45(3):304\u201314.","journal-title":"Neuropharmacology"},{"issue":"1","key":"498_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0091-3057(02)00947-4","volume":"74","author":"S Yamazaki","year":"2002","unstructured":"Yamazaki S, Mochizuki Y, Terai T, Sugimoto M, Uchida I, Matsuoka N, Mutoh S. Intracerebroventricular injection of the antibiotic cefoselis produces convulsion in mice via inhibition of GABA receptors. Pharmacol Biochem Behav. 2002;74(1):53\u20139.","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"498_CR32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.7164\/antibiotics.46.1145","volume":"46","author":"H Seiji","year":"1993","unstructured":"Seiji H, Kanemitsu K, Shimada J. Effect of cephalosporins on y-aminobutyric acid receptor binding with or without non-steroidal anti-inflammatory drugs. J Antibiot. 1993;46(7):1145\u20138.","journal-title":"J Antibiot."},{"issue":"6","key":"498_CR33","doi-asserted-by":"publisher","first-page":"R264","DOI":"10.1186\/cc13094","volume":"17","author":"JE Fugate","year":"2013","unstructured":"Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care. 2013;17(6):R264.","journal-title":"Crit Care."},{"issue":"1","key":"498_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5535\/arm.2012.36.1.159","volume":"36","author":"S-Y Kim","year":"2012","unstructured":"Kim S-Y, Lee I-S, Park SL, Lee J. Cefepime neurotoxicity in patients with renal insufficiency. Ann Rehabil Med. 2012;36(1):159\u201362.","journal-title":"Ann Rehabil Med."},{"issue":"5","key":"498_CR35","doi-asserted-by":"publisher","first-page":"408","DOI":"10.7164\/antibiotics.48.408","volume":"48","author":"M Sunagawa","year":"1995","unstructured":"Sunagawa M, Matsumura H, Sumita Y, Noud H. Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain. J Antibiot. 1995;48(5):408\u201316.","journal-title":"J Antibiot."},{"issue":"1\u20132","key":"498_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.tox.2006.02.004","volume":"222","author":"M Horiuchi","year":"2006","unstructured":"Horiuchi M, Kimura M, Tokumura M, Hasebe N, Arai T, Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with \u03b2-lactam antibiotics. Toxicology. 2006;222(1\u20132):114\u201324.","journal-title":"Toxicology"},{"issue":"8","key":"498_CR37","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/jac\/dku111","volume":"69","author":"JP Cannon","year":"2014","unstructured":"Cannon JP, Lee TA, Clark NM, Setlak P, Grim SA. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother. 2014;69(8):2043\u201355.","journal-title":"J Antimicrob Chemother."},{"issue":"5","key":"498_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/cc6994","volume":"12","author":"TG Slama","year":"2008","unstructured":"Slama TG. Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use. Crit Care. 2008;12(5):233.","journal-title":"Crit Care."},{"issue":"7","key":"498_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/INF.0b013e31828be70b","volume":"32","author":"CP Hornik","year":"2013","unstructured":"Hornik CP, Herring AH, Benjamin DK, et al. Adverse events associated with meropenem versus imipenem\/cilastatin therapy in a large retrospective cohort of hospitalized infants. Pediatr Infect Dis J. 2013;32(7):748\u201353.","journal-title":"Pediatr Infect Dis J."},{"issue":"5","key":"498_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3109\/15376516.2015.1026008","volume":"25","author":"S Ilgin","year":"2015","unstructured":"Ilgin S, Can OD, Atli O, Ucel UI, Sener E, Guven I. Ciprofloxacin-induced neurotoxicity: evaluation of possible underlying mechanisms. Toxicol Mech Methods. 2015;25(5):374\u201381.","journal-title":"Toxicol Mech Methods."},{"issue":"8","key":"498_CR41","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/sj.bjp.0703260","volume":"129","author":"S Marchand","year":"2000","unstructured":"Marchand S, Pariat C, Bouquet S, Courtois P, Couet W. Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats. Br J Pharmacol. 2000;129(8):1609\u201316.","journal-title":"Br J Pharmacol."},{"issue":"11","key":"498_CR42","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2165\/00003088-200140110-00004","volume":"40","author":"F Pea","year":"2001","unstructured":"Pea F, Furlanut M. Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions. Clin Pharmacokinet. 2001;40(11):833\u201368.","journal-title":"Clin Pharmacokinet."},{"issue":"3","key":"498_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/phrs.2001.0853","volume":"44","author":"M Koutsoviti-papadopoulou","year":"2001","unstructured":"Koutsoviti-papadopoulou M, Nikolaidis E, Kounenis G. Biphenylacetic acid enhances the antagonistic action of fluoroquinolones on the gabaA-mediated responses of the isolated guinea-pig ileum. Pharmacol Res. 2001;44(3):229\u201333.","journal-title":"Pharmacol Res"},{"issue":"10","key":"498_CR44","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1128\/AAC.38.10.2323","volume":"38","author":"K Akahane","year":"1994","unstructured":"Akahane K, Kimura Y, Tsutomi Y, Hayakawa I. Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother. 1994;38(10):2323\u20139.","journal-title":"Antimicrob Agents Chemother."},{"issue":"2","key":"498_CR45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/AAC.41.2.427","volume":"41","author":"G Sarro De","year":"1997","unstructured":"De Sarro G, Nava F, Calapai G, De Sarro A. Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA\/2 mice. Antimicrob Agents Chemother. 1997;41(2):427\u201334.","journal-title":"Antimicrob Agents Chemother."},{"key":"498_CR46","doi-asserted-by":"crossref","unstructured":"Lally L, Mannion L. The potential for antimicrobials to adversely affect mental state. BMJ Case Rep. 2013;2013:bcr2013009659.","DOI":"10.1136\/bcr-2013-009659"},{"key":"498_CR47","doi-asserted-by":"crossref","unstructured":"Al Bu Ali WH. Ciprofloxacin-associated posterior reversible encephalopathy. BMJ Case Rep. 2013;2013:bcr2013008636.","DOI":"10.1136\/bcr-2013-008636"},{"issue":"9","key":"498_CR48","first-page":"1291","volume":"43","author":"J Shi","year":"2014","unstructured":"Shi J, Xu H. Moxifloxacin induced seizures -a case report. Iran J Public Health. 2014;43(9):1291\u20134.","journal-title":"Iran J Public Health."},{"key":"498_CR49","doi-asserted-by":"publisher","unstructured":"Ahmed AIA, van der Heijden FMMA, van den Berkmortel H, Kramers K. A man who wanted to commit suicide by hanging himself: an adverse effect of ciprofloxacin. Gen Hosp Psychiatry. 2011;33(1):82.e5\u2013e7.","DOI":"10.1016\/j.genhosppsych.2010.07.002"},{"issue":"1","key":"498_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.psym.2011.05.003","volume":"53","author":"U Labay-Kamara","year":"2012","unstructured":"Labay-Kamara U, Manning S, McMahon T. Fluoroquinolone induced suicidal ideation and suicidality. Psychosomatics. 2012;53(1):97\u20138.","journal-title":"Psychosomatics"},{"issue":"4","key":"498_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-2006-947183","volume":"39","author":"T Steinert","year":"2006","unstructured":"Steinert T, Studemund H. Acute delusional parasitosis under treatment with ciprofloxacin. Pharmacopsychiatry. 2006;39(4):159\u201360.","journal-title":"Pharmacopsychiatry."},{"issue":"8","key":"498_CR52","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1128\/AAC.00672-13","volume":"57","author":"E Ben-Chetrit","year":"2013","unstructured":"Ben-Chetrit E, Rothstein N, Munter G. Ciprofloxacin-induced psychosis. antimicrobial agents and chemotherapy. 2013;57(8):4079.","journal-title":"Ciprofloxacin-induced psychosis. antimicrobial agents and chemotherapy."},{"issue":"2","key":"498_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0253-7613.108316","volume":"45","author":"U Chauhan","year":"2013","unstructured":"Chauhan U, Shanbag P, Kashid P. Ofloxacin-induced hallucinations. Indian J Pharmacol. 2013;45(2):189\u201390.","journal-title":"Indian J Pharmacol."},{"issue":"4","key":"498_CR54","doi-asserted-by":"publisher","first-page":"236","DOI":"10.12968\/hmed.2009.70.4.41632","volume":"70","author":"S Koul","year":"2009","unstructured":"Koul S, Bhan-Kotwal S, Jenkins HS, Carmaciu CD. Organic psychosis induced by ofloxacin and metronidazole. Br J Hosp Med (Lond). 2009;70(4):236\u20137.","journal-title":"Br J Hosp Med (Lond)."},{"issue":"7\u20138","key":"498_CR55","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/106002809202600716","volume":"26","author":"RR Reeves","year":"1992","unstructured":"Reeves RR. Ciprofloxacin-induced psychosis. Ann Pharmacother. 1992;26(7\u20138):930\u20131.","journal-title":"Ann Pharmacother."},{"issue":"6","key":"498_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1176\/appi.psy.47.6.539","volume":"47","author":"S Bhalerao","year":"2006","unstructured":"Bhalerao S, Talsky A, Hansen K, Kingstone E, Schroeder B, Karim Z, Fung I. Ciprofloxacin-induced manic episode. Psychosomatics. 2006;47(6):539\u201340.","journal-title":"Psychosomatics."},{"key":"498_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00004714-200202000-00012","volume":"22","author":"A Abouesh","year":"2002","unstructured":"Abouesh A, Stone C, Hobbs WR. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J Clin Psychopharmacol. 2002;22:71\u201381.","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl 3","key":"498_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000057839","volume":"47","author":"C Carbon","year":"2001","unstructured":"Carbon C. Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy. 2001;47(Suppl 3):9\u201314 (discussion 44\u20138).","journal-title":"Chemotherapy."},{"issue":"345","key":"498_CR59","doi-asserted-by":"publisher","first-page":"e5304","DOI":"10.1136\/bmj.e5304","volume":"6","author":"AR Medford","year":"2012","unstructured":"Medford AR. Fluoroquinolones and theophylline can also lower the seizure threshold. BMJ. 2012;6(345):e5304.","journal-title":"BMJ."},{"issue":"10","key":"498_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pnpbp.2012.09.006","volume":"40","author":"A Jindal","year":"2013","unstructured":"Jindal A, Mahesh R, Kumar B. Anxiolytic-like effect of linezolid in experimental mouse models of anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 2013;40(10):47\u201353.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"498_CR61","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1176\/ajp.2007.164.2.346b","volume":"164","author":"S Packer","year":"2007","unstructured":"Packer S, Berman S. Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid. Am J Psychiatry. 2007;164(2):346\u20137.","journal-title":"Am J Psychiatry."},{"key":"498_CR62","first-page":"617251","volume":"2013","author":"L Samartzis","year":"2013","unstructured":"Samartzis L, Savvari P, Kontogiannis S, Dimopoulos S. Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature. Case Rep Psychiatry. 2013;2013:617251.","journal-title":"Case Rep Psychiatry."},{"issue":"12","key":"498_CR63","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1128\/AAC.00921-13","volume":"57","author":"TP Lodise","year":"2013","unstructured":"Lodise TP, Patel N, Rivera A, et al. Comparative evaluation of serotonin toxicity among veterans affairs patients receiving linezolid and vancomycin. Antimicrob Agents Chemother. 2013;57(12):5901\u201311.","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"498_CR64","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4103\/0253-7176.122245","volume":"35","author":"RR Kulkarni","year":"2013","unstructured":"Kulkarni RR, Kulkarni PR. Linezolid-induced near-fatal serotonin syndrome during escitalopram therapy: case report and review of literature. Indian J Psychol Med. 2013;35(4):413\u20136.","journal-title":"Indian J Psychol Med."},{"issue":"3","key":"498_CR65","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1176\/appi.psy.46.3.274","volume":"46","author":"N Morales","year":"2005","unstructured":"Morales N, Vermette H. Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine. Psychosomatics. 2005;46(3):274\u20135.","journal-title":"Psychosomatics."},{"issue":"2","key":"498_CR66","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1086\/524671","volume":"46","author":"PK Das","year":"2008","unstructured":"Das PK, Warkentin DI, Hewko R, Forrest DL. Serotonin syndrome after concomitant treatment with linezolid and meperidine. Clin Infect Dis. 2008;46(2):264\u20135.","journal-title":"Clin Infect Dis."},{"issue":"7","key":"498_CR67","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1128\/AAC.00431-13","volume":"57","author":"S Flanagan","year":"2013","unstructured":"Flanagan S, Bartizal K, Minassian SL, Fang E, Prokocimer P. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions. Antimicrob Agents Chemother. 2013;57(7):3060\u20136.","journal-title":"Antimicrob Agents Chemother."},{"issue":"2\u20133","key":"498_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2006.06.065","volume":"545","author":"KS Naruganahalli","year":"2006","unstructured":"Naruganahalli KS, Shirumalla RK, Bansal V, Gupta JB, Das B, Ray A. Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious rats. Eur J Pharmacol. 2006;545(2\u20133):167\u201372.","journal-title":"Eur J Pharmacol."},{"issue":"24","key":"498_CR69","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1016\/j.bmcl.2008.10.084","volume":"18","author":"V Jayaprakash","year":"2008","unstructured":"Jayaprakash V, Sinha BN, Ucar G, Ercan A. Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorg Med Chem Lett. 2008;18(24):6362\u20138.","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"498_CR70","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.ejmech.2009.03.024","volume":"44","author":"OA Phillips","year":"2009","unstructured":"Phillips OA, Udo EE, Abdel-Hamid ME, Varghese R. Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazole) methyl oxazolidinones. Eur J Med Chem. 2009;44(8):3217\u201327.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"498_CR71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1093\/jac\/dkr467","volume":"67","author":"JM Butterfield","year":"2012","unstructured":"Butterfield JM, Lawrence KR, Reisman A, Huang DB, Thompson CA, Lodise TP. Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data. J Antimicrob Chemother. 2012;67(2):494\u2013502.","journal-title":"J Antimicrob Chemother."},{"issue":"6","key":"498_CR72","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/jac\/dki368","volume":"56","author":"JA Morales-Molina","year":"2005","unstructured":"Morales-Molina JA, Antonio JM-D, Mar\u00edn-Casino M, Grau S. Linezolid-associated serotonin syndrome: what we can learn from cases reported so far. J Antimicrob Chemother. 2005;56(6):1176\u20138.","journal-title":"J Antimicrob Chemother."},{"issue":"11","key":"498_CR73","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1086\/503839","volume":"42","author":"KR Lawrence","year":"2006","unstructured":"Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis. 2006;42(11):1578\u201383.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"498_CR74","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0884533610368711","volume":"25","author":"MM Rumore","year":"2010","unstructured":"Rumore MM, Roth M, Orfanos A. Dietary tyramine restriction for hospitalized patients on linezolid: an update. Nutr Clin Pract. 2010;25(3):265\u20139.","journal-title":"Nutr Clin Pract."},{"issue":"8","key":"498_CR75","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2174\/138920007782798216","volume":"8","author":"P Preziosi","year":"2007","unstructured":"Preziosi P. Isoniazid: metabolic aspects and toxicological correlates. Curr Drug Metab. 2007;8(8):839\u201351.","journal-title":"Curr Drug Metab."},{"issue":"10","key":"498_CR76","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1358\/mf.2000.22.10.802292","volume":"22","author":"PS Naidu","year":"2000","unstructured":"Naidu PS, Kulkarni SK. Differential role of dopamine D1 and D2 receptors in isoniazid-induced vacuous chewing movements. Methods Find Exp Clin Pharmacol. 2000;22(10):747\u201351.","journal-title":"Methods Find Exp Clin Pharmacol."},{"key":"498_CR77","doi-asserted-by":"crossref","unstructured":"Rya S, Sukhija G, Singh H. Acute psychosis after recent isoniazid initiation. J Clin Diagn Res JCDR. 2015;9(6):VD01\u2013VD02.","DOI":"10.7860\/JCDR\/2015\/12450.6130"},{"issue":"2","key":"498_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/00063110-200504000-00007","volume":"12","author":"P Lheureux","year":"2005","unstructured":"Lheureux P, Penaloza A, Gris M. Pyridoxine in clinical toxicology: a review. Eur J Emerg Med. 2005;12(2):78\u201385.","journal-title":"Eur J Emerg Med."},{"issue":"4","key":"498_CR79","first-page":"749","volume":"57","author":"JA Romero","year":"1998","unstructured":"Romero JA, Kuczler FJ Jr. Isoniazid overdose: recognition and management. Am Fam Physician. 1998;57(4):749\u201352.","journal-title":"Am Fam Physician."},{"key":"498_CR80","doi-asserted-by":"publisher","unstructured":"Neurotoxic effects of isoniazid. Br Med J. 1958;1(5075):880\u20131.","DOI":"10.1136\/bmj.1.5075.880"},{"issue":"10","key":"498_CR81","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/cap.2014.0065","volume":"25","author":"BM Burak","year":"2015","unstructured":"Burak BM, Serpil E, Tezan B, Bylent K. Isoniazid-induced psychosis with obsessive-compulsive symptoms (schizo-obsessive disorder) in a female child. J Child Adolesc Psychopharmacol. 2015;25(10):819\u201320.","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"3","key":"498_CR82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0041-3879(79)90019-9","volume":"60","author":"GS Sharma","year":"1979","unstructured":"Sharma GS, Gupta PK, Jain NK, Shanker A, Nanawati V. Toxic psychosis to isoniazid and ethionamide in a patient with pulmonary tuberculosis. Tubercle. 1979;60(3):171\u20132.","journal-title":"Tubercle."},{"issue":"5","key":"498_CR83","first-page":"8249","volume":"8","author":"C Qu","year":"2015","unstructured":"Qu C, Li X, Zheng Z, Zhu J. Successful diagnosis of hyperpyrexia induced by isoniazid in a child with suspected extra-pulmonary tuberculosis. Int J Clin Exp Med. 2015;8(5):8249\u201353.","journal-title":"Int J Clin Exp Med."},{"key":"498_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.exer.2013.05.018","volume":"113","author":"C Sun","year":"2013","unstructured":"Sun C, Li X-X, He X-J, Zhang Q, Tao Y. Neuroprotective effect of minocycline in a rat model of branch retinal vein occlusion. Exp Eye Res. 2013;113:105\u201316.","journal-title":"Exp Eye Res"},{"issue":"6","key":"498_CR85","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/exd.12692","volume":"24","author":"F Regen","year":"2015","unstructured":"Regen F, Hildebrand M, Le Bret N, Herzog I, Heuser I, Hellmann-Regen J. Inhibition of retinoic acid catabolism by minocycline: evidence for a novel mode of action? Exp Dermatol. 2015;24(6):473\u20136.","journal-title":"Exp Dermatol."},{"issue":"12","key":"498_CR86","doi-asserted-by":"publisher","first-page":"e51270","DOI":"10.1371\/journal.pone.0051270","volume":"7","author":"LJ Campbell","year":"2012","unstructured":"Campbell LJ, Willoughby JJ, Jensen AM. Two types of tet-on transgenic lines for doxycycline-inducible gene expression in zebrafish rod photoreceptors and a gateway-based tet-on toolkit. PLoS One. 2012;7(12):e51270.","journal-title":"PLoS One."},{"issue":"1","key":"498_CR87","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.nbd.2006.09.008","volume":"25","author":"R M\u00e5nsson","year":"2007","unstructured":"M\u00e5nsson R, Hansson MJ, Morota S, Uchino H, Ekdahl CT, Elm\u00e9r E. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline. Neurobiol Dis. 2007;25(1):198\u2013205.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"498_CR88","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00213-001-0989-7","volume":"160","author":"P Munzar","year":"2002","unstructured":"Munzar P, Li H, Nicholson KL, Wiley JL, Balster RL. Enhancement of the discriminative stimulus effects of phencyclidine by the tetracycline antibiotics doxycycline and minocycline in rats. Psychopharmacology (Berl). 2002;160(3):331\u20136.","journal-title":"Psychopharmacology (Berl)."},{"key":"498_CR89","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.neuropharm.2013.08.031","volume":"75","author":"W Makuch","year":"2013","unstructured":"Makuch W, Mika J, Rojewska E, Zychowska M, Przewlocka B. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Neuropharmacology. 2013;75:445\u201357.","journal-title":"Neuropharmacology"},{"key":"498_CR90","doi-asserted-by":"publisher","unstructured":"Atigari OV, Hogan C, Healy D. Doxycycline and suicidality. BMJ Case Rep. 2013. doi: 10.1136\/bcr-2013-200723 .","DOI":"10.1136\/bcr-2013-200723"},{"key":"498_CR91","doi-asserted-by":"publisher","unstructured":"Baratta JM, Dyck PJB, Brand P, Thaisetthawatkul P, Dyck PJ, Engelstad JK, et al. Vasculitic neuropathy following exposure to minocycline. Neurol Neuroimmunol Neuroinflamm. 2016;3(1):e180.","DOI":"10.1212\/NXI.0000000000000180"},{"issue":"5","key":"498_CR92","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/ana.22299","volume":"69","author":"S Rasmussen","year":"2011","unstructured":"Rasmussen S, Imitola J, Ayuso-Sacido A, et al. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol. 2011;69(5):878\u201391.","journal-title":"Ann Neurol."},{"issue":"1\u20132","key":"498_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.04.006","volume":"235","author":"X Chen","year":"2011","unstructured":"Chen X, Ma X, Jiang Y, Pi R, Liu Y, Ma L. The prospects of minocycline in multiple sclerosis. J Neuroimmunol. 2011;235(1\u20132):1\u20138.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"498_CR94","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/0269881112444941","volume":"26","author":"G Dunn","year":"2012","unstructured":"Dunn G, Deakin B. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. 1. J Psychopharmacol. 2012;26(9):1185\u201393.","journal-title":"J Psychopharmacol."},{"issue":"1\u20133","key":"498_CR95","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","volume":"153","author":"F Liu","year":"2014","unstructured":"Liu F, Guo X, Wu R, Ou J, Zheng Y, Zhang B, Xie L, Zhang L, Yang L, Yang S, Yang J, Ye Y, Zeng Y, Xu X, Zhao J. Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial. Schizophr Res. 2014;153(1\u20133):169\u201376.","journal-title":"Schizophr Res"},{"issue":"1","key":"498_CR96","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","volume":"1630","author":"H Kumar","year":"2016","unstructured":"Kumar H, Sharma B. Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats. Brain Res. 2016;1630(1):83\u201397.","journal-title":"Brain Res"},{"issue":"1","key":"498_CR97","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1866-1955-5-9","volume":"5","author":"CA Pardo","year":"2013","unstructured":"Pardo CA, Buckley A, Thurm A, et al. A pilot open-label trial of minocycline in patients with autism and regressive features. J Neurodev Disord. 2013;5(1):9.","journal-title":"J Neurodev Disord."},{"issue":"1","key":"498_CR98","doi-asserted-by":"publisher","first-page":"e000643","DOI":"10.1136\/bmjopen-2011-000643","volume":"2","author":"J Savitz","year":"2012","unstructured":"Savitz J, Preskorn S, Teague TK, Drevets D, Yates W, Drevets W. Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2\u00a0\u00d7\u00a02 clinical trial. BMJ Open. 2012;2(1):e000643.","journal-title":"BMJ Open."},{"key":"498_CR99","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s13063-015-0933-5","volume":"16","author":"MI Husain","year":"2015","unstructured":"Husain MI, Chaudhry IB, Rahman RR, et al. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial. Trials. 2015;16:410.","journal-title":"Trials."},{"issue":"6","key":"498_CR100","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1542\/peds.2004-1352","volume":"115","author":"M Saidinejad","year":"2005","unstructured":"Saidinejad M, Ewald MB, Shannon MW. Transient psychosis in an immune-competent patient after oral trimethoprim\u2013sulfamethoxazole administration. Pediatrics. 2005;115(6):e739\u201341.","journal-title":"Pediatrics."},{"issue":"6","key":"498_CR101","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-2006-950393","volume":"39","author":"S Weis","year":"2006","unstructured":"Weis S, Karag\u00fclle D, Kornhuber J, Bayerlein K. Cotrimoxazole-induced psychosis: a case report and review of literature. Pharmacopsychiatry. 2006;39(6):236\u20137.","journal-title":"Pharmacopsychiatry"},{"key":"498_CR102","doi-asserted-by":"publisher","unstructured":"Stuhec M. Trimethoprim-sulfamethoxazole-related hallucinations. Gen Hospital Psychiatry. 2014;36(2):230.e7\u2013230.e8.","DOI":"10.1016\/j.genhosppsych.2013.10.016"},{"issue":"11","key":"498_CR103","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1093\/jac\/dks283","volume":"67","author":"K-Y Lee","year":"2012","unstructured":"Lee K-Y, Huang C-H, Tang H-J, Yang C-J, Ko W-C, Chen Y-H, Lee Y-C, Hung C-C. Acute psychosis related to use of trimethoprim\/sulfamethoxazole in the treatment of HIV-infected patients with Pneumocystis jirovecii pneumonia: a multicentre, retrospective study. J Antimicrob Chemother. 2012;67(11):2749\u201354.","journal-title":"J Antimicrob Chemother."},{"key":"498_CR104","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jnnp.57.6.705","volume":"57","author":"Y River","year":"1994","unstructured":"River Y, Averbuch-Heller L, Weinberger M, Meiner Z, Mevorach D, Schlesinger I, Argov Z. Antibiotic induced meningitis. J Neurol Neurosurg Psychiatry. 1994;57:705\u20138.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4","key":"498_CR105","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/schbul\/sbn191","volume":"36","author":"T Shibre","year":"2010","unstructured":"Shibre T, Alem A, Abdulahi A, et al. Trimethoprim as adjuvant treatment in schizophrenia: a double-blind, randomized, placebo-controlled clinical trial. Schizophr Bull. 2010;36(4):846\u201351.","journal-title":"Schizophr Bull."},{"issue":"12","key":"498_CR106","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00701-011-1102-6","volume":"153","author":"A Sevy","year":"2011","unstructured":"Sevy A, Moyse E, Million M, Battaglia F. Central and peripheral neurotoxicity of metronidazole after treatment for brain abscess. Acta Neurochirurgica. 2011;153(12):2491\u20132.","journal-title":"Acta Neurochirurgica."},{"key":"498_CR107","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0028-3886.76848","volume":"2011","author":"V Puri","year":"2011","unstructured":"Puri V. Metronidazole neurotoxicity. Neurol India. 2011;2011:4\u20135.","journal-title":"Neurol India."},{"issue":"7","key":"498_CR108","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/jnnp.2008.165308","volume":"81","author":"ANV Moosa","year":"2010","unstructured":"Moosa ANV, Perkins D. MRI of metronidazole induced cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2010;81(7):754\u20135.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"498_CR109","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/0028-3886.76882","volume":"59","author":"KI Park","year":"2011","unstructured":"Park KI, Chung JM, Kim JY. Metronidazole neurotoxicity: sequential neuroaxis involvement. Neurol India. 2011;59:104\u20137.","journal-title":"Neurol India"},{"key":"498_CR110","first-page":"103","volume":"114","author":"DR Petersen","year":"1982","unstructured":"Petersen DR, Hjelle JJ. Metabolic interactions of aldehyde dehydrogenase with therapeutic and toxic agents. Prog Clin Biol Res. 1982;114:103\u201320.","journal-title":"Prog Clin Biol Res."},{"issue":"6","key":"498_CR111","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1345\/aph.1A066","volume":"36","author":"JP Visap\u00e4\u00e4","year":"2002","unstructured":"Visap\u00e4\u00e4 JP, Tillonen JS, Kaihovaara PS, Salaspuro MP. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002;36(6):971\u20134.","journal-title":"Ann Pharmacother."},{"issue":"Suppl 2","key":"498_CR112","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1007\/PL00022395","volume":"50","author":"O Befani","year":"2001","unstructured":"Befani O, Grippa E, Saso L, Turini P, Mondov\u00ec B. Inhibition of monoamine oxidase by metronidazole. Inflamm Res. 2001;50(Suppl 2):S136\u20137.","journal-title":"Inflamm Res."},{"key":"498_CR113","first-page":"209258","volume":"2012","author":"JP Knorr","year":"2012","unstructured":"Knorr JP, Javed I, Sahni N, Cankurtaran CZ, Ortiz JA. Metronidazole-induced encephalopathy in a patient with end-stage liver disease. Case Rep Hepatol. 2012;2012:209258.","journal-title":"Case Rep Hepatol."},{"issue":"4","key":"498_CR114","first-page":"295","volume":"4","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y. Metronidazole-induced neurotoxicity developed in liver cirrhosis. J Clin Med Res. 2012;4(4):295\u20138.","journal-title":"J Clin Med Res."},{"issue":"2","key":"498_CR115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.31887\/DCNS.2003.5.2\/rcasagrandetango","volume":"5","author":"Tango R Casagrande","year":"2003","unstructured":"Casagrande Tango R. Psychiatric side effects of medications prescribed in internal medicine. Dialog Clin Neurosci. 2003;5(2):155\u201365.","journal-title":"Dialog Clin Neurosci."},{"key":"498_CR116","unstructured":"Salafia A, Candida. Rifampicin induced flu-syndrome and toxic psychosis. Indian J Lepr. 1992;64(4):537\u20139."},{"issue":"1","key":"498_CR117","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.brainres.2006.01.116","volume":"1082","author":"Y Oida","year":"2006","unstructured":"Oida Y, Kitaichi K, Nakayama H, Ito Y, Fujimoto Y, Shimazawa M, Nagai H, Hara H. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain. Brain Res. 2006;1082(1):196\u2013204.","journal-title":"Brain Res"},{"issue":"12","key":"498_CR118","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","volume":"271","author":"T Tomiyama","year":"1996","unstructured":"Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H, Endo N. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem. 1996;271(12):6839\u201344.","journal-title":"J Biol Chem."},{"issue":"4","key":"498_CR119","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/1817-1737.43083","volume":"3","author":"R Prasad","year":"2008","unstructured":"Prasad R, Garg R, Verma SK. Isoniazid- and ethambutol-induced psychosis. Ann Thorac Med. 2008;3(4):149\u201351.","journal-title":"Ann Thorac Med."},{"issue":"11","key":"498_CR120","doi-asserted-by":"publisher","first-page":"7052","DOI":"10.1167\/iovs.12-10308","volume":"53","author":"J Kinoshita","year":"2012","unstructured":"Kinoshita J, Iwata N, Maejima T, Kimotsuki T, Yasuda M. Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy. Invest Ophthalmol Vis Sci. 2012;53(11):7052\u201362.","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"19","key":"498_CR121","first-page":"2953","volume":"18","author":"E Uzar","year":"2014","unstructured":"Uzar E, Varol S, Acar A, Firat U, Basarslan SK, Evliyaoglu O, Yucel Y, Alp H, G\u0161kalp O. Assesment the role of oxidative stress and efficacy of caffeic acid phenethyl ester (CAPE) on neurotoxicity induced by isoniazidand ethambutol in a rat model. Eur Rev Med Pharmacol Sci. 2014;18(19):2953\u20139.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"6","key":"498_CR122","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4088\/JCP.14l09527","volume":"76","author":"JT Kantrowitz","year":"2015","unstructured":"Kantrowitz JT, Halberstam B, Gangwisch J. Single-dose ketamine followed by daily d-cycloserine in treatment-resistant bipolar depression. J Clin Psychiatry. 2015;76(6):737\u20138.","journal-title":"J Clin Psychiatry."},{"issue":"1\u20133","key":"498_CR123","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.schres.2011.05.029","volume":"131","author":"JD Gottlieb","year":"2011","unstructured":"Gottlieb JD, Cather C, Shanahan M, Creedon T, Macklin EA, Goff DC. d-Cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia. Schizophr Res. 2011;131(1\u20133):69\u201374.","journal-title":"Schizophr Res."},{"issue":"4","key":"498_CR124","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0006-3223(98)00367-9","volume":"45","author":"DC Goff","year":"1999","unstructured":"Goff DC, Henderson DC, Evins AE, Amico E. A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia. Biol Psychiatry. 1999;45(4):512\u20134.","journal-title":"Biol Psychiatry."},{"issue":"5","key":"498_CR125","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/schbul\/sbs069","volume":"38","author":"DC Javitt","year":"2012","unstructured":"Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D. Has an angel shown the way? Etiological and therapeutic implications of the PCP\/NMDA model of schizophrenia. Schizophr Bull. 2012;38(5):958\u201366.","journal-title":"Schizophr Bull."},{"issue":"2","key":"498_CR126","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2011.01.028","volume":"219","author":"Y-J Ho","year":"2011","unstructured":"Ho Y-J, Ho S-H, Pawlak CR, Yeh K-Y. Effects of d-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson\u2019s disease dementia. Behav Brain Res. 2011;219(2):280\u201390.","journal-title":"Behav Brain Res"},{"key":"498_CR127","doi-asserted-by":"publisher","unstructured":"Schade S, Paulus W. D-Cycloserine in neuropsychiatric diseases: a systematic review. Int J Neuropsychopharmacol. 2016;19(4):pyv102.","DOI":"10.1093\/ijnp\/pyv102"},{"issue":"2","key":"498_CR128","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4103\/0253-7613.153439","volume":"47","author":"VR Tandon","year":"2015","unstructured":"Tandon VR, Rani N, Roshi, et al. Cycloserine induced psychosis with hepatic dysfunction. Indian J Pharmacol. 2015;47(2):230\u20131.","journal-title":"Indian J Pharmacol."},{"key":"498_CR129","doi-asserted-by":"publisher","unstructured":"Holla S, Amberkar MB, Bhandarypanambur R, Kamalkishore M, Janardhanan M. Cycloserine induced late onset psychosis and ethambutol induced peripheral neuropathy associated with MDR-TB treatment in an indian patient\u2014a rare case report. J Clin Diagn Res. 2015;9(2):FD01\u201303.","DOI":"10.7860\/JCDR\/2015\/12417.5588"},{"issue":"2","key":"498_CR130","first-page":"98","volume":"5","author":"G Leggeri","year":"1951","unstructured":"Leggeri G. Case report of a psychosis caused by streptomycin. Rass Neuropsichiatr. 1951;5(2):98\u2013106.","journal-title":"Rass Neuropsichiatr."},{"issue":"10","key":"498_CR131","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/00007611-197510000-00025","volume":"68","author":"FJ Kane Jr","year":"1975","unstructured":"Kane FJ Jr, Byrd G. Acute toxic psychosis associated with gentamicin therapy. South Med J. 1975;68(10):1283\u20135.","journal-title":"South Med J."},{"key":"498_CR132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-244X-1-5","volume":"1","author":"R Manev","year":"2001","unstructured":"Manev R, Manev H. Aminoglycoside antibiotics and autism: a speculative hypothesis. BMC Psychiatry. 2001;1:5.","journal-title":"BMC Psychiatry."},{"issue":"6","key":"498_CR133","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ana.410040618","volume":"4","author":"I Watanabe","year":"1978","unstructured":"Watanabe I, Hodges GR, Dworzack DL, Kepes JJ, Duensing GF. Neurotoxicity of intrathecal gentamicin: a case report and experimental study. Ann Neurol. 1978;4(6):564\u201372.","journal-title":"Ann Neurol."},{"issue":"2","key":"498_CR134","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0006-8993(98)01123-8","volume":"815","author":"JA Segal","year":"1999","unstructured":"Segal JA, Harris BD, Kustova Y, Basile A, Skolnick P. Aminoglycoside neurotoxicity involves NMDA receptor activation. Brain Res. 1999;815(2):270\u20137.","journal-title":"Brain Res"},{"issue":"3","key":"498_CR135","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1515\/JPM.2003.032","volume":"31","author":"A Poblano","year":"2003","unstructured":"Poblano A, Belmont A, Sosa J, Ibarra J, Vargas AM, Liman G, Martinez C. Amikacin alters auditory brainstem conduction time in newborns. J Perinat Med. 2003;31(3):237\u201341.","journal-title":"J Perinat Med."},{"issue":"3","key":"498_CR136","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF02828147","volume":"25","author":"C Liu","year":"2005","unstructured":"Liu C, Hu F. Investigation on the mechanism of exacerbation of myasthenia gravis by aminoglycoside antibiotics in mouse model. J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):294\u20136.","journal-title":"J Huazhong Univ Sci Technolog Med Sci."},{"issue":"2","key":"498_CR137","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1128\/AAC.01088-08","volume":"53","author":"A Forouzesh","year":"2009","unstructured":"Forouzesh A, Moise PA, Sakoulas G. Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother. 2009;53(2):483\u20136.","journal-title":"Antimicrob Agents Chemother."},{"issue":"4","key":"498_CR138","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/phar.1577","volume":"35","author":"DM Gomes","year":"2015","unstructured":"Gomes DM, Ward KE, LaPlante KL. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy. 2015;35(4):424\u201332.","journal-title":"Pharmacotherapy."},{"issue":"11","key":"498_CR139","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/jnnp.50.11.1419","volume":"50","author":"R Bayston","year":"1987","unstructured":"Bayston R, Hart CA, Barnicoat M. Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage. J Neurol Neurosurg Psychiatry. 1987;50(11):1419\u201323.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"498_CR140","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/clinids\/19.1.163","volume":"19","author":"GA Losonsky","year":"1994","unstructured":"Losonsky GA, Wolf A, Schwalbe RS, Nataro J, Gibson CB, Lewis EW. Successful treatment of meningitis due to multiply resistant Enterococcus faecium with a combination of intrathecal teicoplanin and intravenous antimicrobial agents. Clin Infect Dis. 1994;19(1):163\u20135.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"498_CR141","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000109868","volume":"81","author":"R Sauermann","year":"2008","unstructured":"Sauermann R, Rothenburger M, Graninger W, Joukhadar C. Daptomycin: a review 4\u00a0years after first approval. Pharmacology. 2008;81(2):79\u201391.","journal-title":"Pharmacology."},{"issue":"6","key":"498_CR142","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/jac\/dkp127","volume":"63","author":"RO Odero","year":"2009","unstructured":"Odero RO, Cleveland KO. Gelfand MS Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor1. J Antimicrob Chemother. 2009;63(6):1299\u2013300.","journal-title":"J Antimicrob Chemother."},{"issue":"6","key":"498_CR143","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1179\/joc.2010.22.6.434","volume":"22","author":"F Sbrana","year":"2010","unstructured":"Sbrana F, Di Paolo A, Pasanisi EM, Tagliaferri E, Arvia C, Puntoni M, Leonildi A, Bigazzi F, Danesi R, Rovai D, Tascini C, Menichetti F. Administration interval and daptomycin toxicity: a case report of rhabdomyolysis. J Chemother. 2010;22(6):434\u20135.","journal-title":"J Chemother."},{"issue":"7","key":"498_CR144","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/00365548.2014.901555","volume":"46","author":"ST King","year":"2014","unstructured":"King ST, Walker ED, Cannon CG, Finley RW. Daptomycin-induced rhabdomyolysis and acute liver injury. Scand J Infect Dis. 2014;46(7):537\u201340.","journal-title":"Scand J Infect Dis."},{"issue":"10","key":"498_CR145","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1177\/1060028014542634","volume":"48","author":"TH Denetclaw","year":"2014","unstructured":"Denetclaw TH, Suehiro I, Wang PK, Tolliver GL. Successful treatment of ventriculostomy-associated meningitis caused by multidrug resistant coagulase-negative Staphylococcus epidermidis using low-volume intrathecal daptomycin and loading strategy. Ann Pharmacother. 2014;48(10):1376\u20139.","journal-title":"Ann Pharmacother."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-017-0498-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-017-0498-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T03:33:08Z","timestamp":1658633588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-017-0498-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":145,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1007\/s40261-017-0498-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}